Rhenman & Partners Asset Management AB

STOCKHOLM, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$902.9M2026 Q3
Positions93
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.30.0%

Rhenman & Partners Asset Management AB reported 93 positions worth $902.9M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: IOVA (4.1%). Biggest move: reduce SYK ($17.6M).

10 / 93 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 IOVAIovance Biotherapeutics$37.1M4.11%2,502,577——-49.1%
▸ 2 AZNAstraZeneca$30.3M3.35%185,000——+14.0%
▸ 3 MRKMerck$30.1M3.33%206,900——-0.6%
▸ 4 MDTMedtronic$29.3M3.25%340,000——+19.2%
▸ 5 UNHUnitedHealth$26.2M2.90%71,400——+12.2%
▸ 6 VRTXVertex Pharmaceuticals Inc$25.6M2.83%48,935——+2.9%
▸ 7 GILDGilead Sciences$23.7M2.63%159,050——+12.4%
▸ 8 EWEdwards Lifesciences$23.6M2.61%273,000——+24.1%
▸ 9 BMRNBiomarin Pharmaceutical$23.2M2.57%386,900——-3.3%
▸ 10 BIIBBiogen$21.9M2.43%97,050——+11.4%

Pro Feature

The remaining 83 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Rhenman & Partners Asset Management AB hold as of Q3 2026?

Rhenman & Partners Asset Management AB reported 93 positions worth $902.9M in its Q3 2026 13F filing. Largest positions: IOVA (4.1%), AZN (3.4%), MRK (3.3%), MDT (3.2%) and UNH (2.9%).

What did Rhenman & Partners Asset Management AB buy in Q3 2026?

New positions: UTHR, VERA, CYTK, HUM and SMMT (15 in all). Added to: MDT, IOVA, VRTX, COO and AXSM (27 in all).

What did Rhenman & Partners Asset Management AB sell in Q3 2026?

Reduced: SYK, GKOS, TMO, ABBV and THC (49 in all). Sold out entirely: NTRA, ELV, MLYS, ALGN and MLTX (21 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.